You will move to an external webpage. Are you sure?

Nobelpharma

News & Press Release

  • 2023-05-29 Announcements

“HYFTOR” Receives Marketing Authorization in EU for Facial Angiofibroma associated with Tuberous Sclerosis Complex

  1. 前の記事へ
  2. 一覧へ戻る（英語）
  3. 次の記事へ
PAGE TOP
  1. HOME
  2. News & Press Release
  3. “HYFTOR” Receives Marketing Authorization in EU for Facial Angiofibroma associated with Tuberous Sclerosis Complex